InvestWiser

Arcticzymes Technologies ASA

AZTOslo BørsHealthcareMarket value 1.1 bn NOK
21.00NOK −0.5%
last day · Price as of 18 November 2026

The answer first

Does Arcticzymes Technologies beat the market?

No, Arcticzymes Technologies has not beaten the market over the last year.

Arcticzymes Technologies−5.4%Oslo Børs (OSEBX)+29.5%
  • The ranking · Quality, value and trend combined

    Better than 44% of Nordic stocks

    • Quality79
    • Value14
    • Trend55

    No. 72 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Arcticzymes Technologies keeps must grow about 24% a year for 10 years.

Max for seven days

Follow Arcticzymes Technologies with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Arcticzymes Technologies

From today, at a price of 21.00 NOK. Write why you follow Arcticzymes Technologies, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Arcticzymes Technologies

Your first answer is free, no account needed.

Do you own Arcticzymes Technologies, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Arcticzymes Technologies and a few more. Free, no card.

Past year against the exchange and Super Stock
Arcticzymes Technologies−5.4%Oslo Børs (OSEBX)+29.5%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Arcticzymes Technologies has fallen 5.4% over the past year, including dividends.
  • Overall, Arcticzymes Technologies ranks better than 44% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 86.4%. The price is 81.1% below its peak now.

What do analysts think of Arcticzymes Technologies?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

44

Quality, value and trend together. Better than 44% of Nordic stocks.

No. 72 of 195 in healthcare

Quality79
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 56 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.06
  • Asset turnoverSales divided by everything the company owns0.34
  • Return on equityProfit divided by equity+4.0%
  • Cash conversionOperating cash flow divided by profit1.54

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value14
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 121 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity3.0
  • P/SPrice divided by sales8.1
  • P/EPrice divided by earnings75.5
  • P/CFPrice divided by operating cash flow49.1

The ranking is built on P/E, P/B and P/S.

Trend55
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 69 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+1.0%
  • 6 months+5.5%
  • 9 months−8.7%
  • 12 months−5.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+11.4%
3 years, per year
−18.1%
5 years, per year
−25.9%
10 years, per year
+4.8%
Largest fall, 3 years
−86.4%
From a peak to the bottom
From the peak now
−81.1%
How far the price is from the peak
Volatility, 1 year
46.1%
How much the price swings over a year
Beta, 1 year
0.55
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Arcticzymes Technologies

7 funds we follow own Arcticzymes Technologies. The share is how much of the fund the stock makes up.

  • Norway5
  • Sweden2

From the funds' latest known holdings.

About Arcticzymes Technologies

Arcticzymes Technologies ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 50 employees.

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA.

See the full analysis of Arcticzymes Technologies.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market